Elsevier

Biochemical Pharmacology

Volume 50, Issue 12, 22 December 1995, Pages 2047-2056
Biochemical Pharmacology

Research paper
Distribution and induction of CYP3A1 and CYP3A2 in rat liver and extrahepatic tissues

https://doi.org/10.1016/0006-2952(95)02107-8Get rights and content

Abstract

Previously, we have shown that highly specific antibodies against cytochrome P450 enzymes can be produced by targeting a 5-amino acid sequence at the C-terminus. Although rat CYP3A1 and CYP3A2 share 89% amino acid sequence similarity, they differ by 3 out of 5 of their C-terminal residues. In an effort to produce antibodies specific to each form, rabbits were immunised with the peptides IITGS and VINGA, corresponding to the C-termini of CYP3A1 and CYP3A2, respectively. Both antibodies bound strongly to hepatic microsomal fraction from rats treated with pregnenolone 16α-carbonitrile (PCN) in enzyme-linked immunosorbent assay. Binding of the anti-IITGS antibody was strongly inhibited by incubation with IITGS, but VINGA was 60 times less effective. Conversely, binding of the anti-VINGA antibody was inhibited by VINGA 100 times more effectively than IITGS. Similar inhibition of antibody binding was also found using immunoblotting. Immujnoadsorption using the anti-IITGS antibody yielded a single protein from solubilised hepatic microsomal fraction from PCN-treated rats, which was recognised only by the anti-IITGS antibody. Both antibodies bound to single proteins in the liver which were increased following treatment with PCN, but only the anti-IITGS antibody recognised protein in the lung, small intestine, and kidney of untreated and PCN-treated rats. Also, the binding of the two antibodies to hepatic and extrahepatic microsomal fractions from uninduced and induced rats showed differences in the expression of proteins recognised by the two antibodies, providing further evidence of antibody specificity. Thus, the binding of anti-IITGS and anti-VINGA antibodies is mutually exclusive and consistent with specific binding to their target antigens, CYP3A1 and CYP3A2, respectively. Immunocytochemistry was used to determine the distribution of CYP3A1 and CYP3A2. In the liver of untreated animals, both CYP3A1 and CYP3A2 were found to be expressed in the centrilobular region. However, some CYP3A1 immunoreactivity was also detected in many, but not all, hepatocytes throughout the lobule. However, following treatment of rats with PCN, both CYP3A1 and CYP3A2 were found to be strongly expressed in hepatocytes throughout the lobule, although CYP3A2 showed greater expression in the centrilobular region. PCN treatment was also found to result in induction of CYP3A1 in specific regions of the small intestine, lung, and kidney.

References (38)

  • SS Park et al.

    Preparation and characterization of monoclonal antibodies to pregnenolone 16-alpha-carbonitrile inducible rat liver cytochrome P-450

    Biochem Pharmacol

    (1986)
  • JR Halpert

    Multiplicity of steroid-inducible cytochromes P-450 in rat liver microsomes

    Arch Biochem Biophys

    (1988)
  • S Kirita et al.

    cDNA cloning and characterization of a novel member of steroid-induced cytochrome P450 3A in rats

    Arch Biochem Biophys

    (1993)
  • MB Telhada et al.

    Effect of dexamethasone and phenobarbital on run-on transcription rate and CYP3A mRNA concentration in rat liver: changes during development

    Arch Biochem Biophys

    (1992)
  • JC Kolars et al.

    Heterogeneity of cytochrome P450IIIA expression in rat gut epithelia

    Gastroenterology

    (1992)
  • P Schmiedlin-Ren et al.

    Cultured adult rat jejunal explants as a model for studying regulation of CYP3A

    Biochem Pharmacol

    (1993)
  • JR Foster et al.

    Immunocytochemical localization of cytochrome P-450 in hepatic and extra-hepatic tissues of the rat with a monoclonal antibody against cytochrome P-450c

    Biochem Pharmacol

    (1986)
  • AY Lu et al.

    Multiplicity of mammalian microsomal cytochromes P-450

    Pharmacol Rev

    (1979)
  • DR Nelson et al.

    The P450 superfamily: update on new sequences, gene mapping, accession numbers, early trivial names of enzymes, and nomenclature

    DNA Cell Biol

    (1993)
  • Cited by (101)

    • Induction of CYP3A by Morroniside in rats

      2015, Journal of Pharmacological Sciences
    • Treprostinil Improves Hepatic Cytochrome P450 Activity during Rat Liver Transplantation

      2012, Journal of Clinical and Experimental Hepatology
      Citation Excerpt :

      Liver graft microsomes were used to study effects of treprostinil on the protein expression of the three major CYP450 enzymes, CYP3A2, CYP2C11, and CYP2E1, at 48 h post-OLT by Western immunoblotting. Rat CYP3A1 and CYP3A2 share 89% homology16 and treprostinil significantly improved CYP3A2 protein levels by 2.3-fold that of placebo (Figure 3A). The most notable effect of treprostinil occurred with CYP2E1, where treprostinil restored CYP2E1 protein expression to 100%, vs. 64% of normal in the placebo-treated group (Figure 3B).

    View all citing articles on Scopus
    View full text